Efektifitas Perbandingan Kombinasi Clindamycin dan Ekstrak Nannochloropsis Oculata Terhadap Peningkatan Kepadatan Kolagen pada Osteomielitis Mandibula

Authors

  • Faidha Azmi N Sarjana Kedokteran Gigi Universitas Hang Tuah
  • Dian Mulawarmanti Biokimia Fakultas Kedokteran Gigi Universitas Hang Tuah
  • Noengki Prameswari Biomedik Fakultas Kedokteran gigi Universitas Hang Tuah

Keywords:

Nannochloropsis oculata, collagen, osteomyelitis

Abstract

Background: Osteomyelitis is an bone infection caused by bacteria of Staphylococcus aureus. The use of clindamycin within long term may cause of resistance. A compound in Nannochloropsis oculata’s extract contain antibacterial, antiinflamation, antioxidant that can be used as therapy of osteomyielitis. Purpose: Knowing comparison of the effectiveness between the combination of clindamycin and Nannochloropsis oculata’s extract to increasing the density of collagen on the mandibular osteomyelitis. Materials and Methods: The experimental research’s type with a design post test only control group. Fourty male wistar rats as model of mandibular osteomyelitis has made by inducing bacteria of Staphylococcus aureus inserted in socket after an extraction of left incisive teeth on lower jaw and waiting for 28 days. The rats are divided into 5 group: negative control (K1), clindamycin (K2),
clindamycin with 50mg Nannochloropsis oculata’s extract (K3), clindamycin with 100mg Nannochloropsis oculata’s extract (K4), clindamycin with 200mg Nannochloropsis oculata’s extract. After 7 days, all of group are euthanazed and then the density of collagen measured using histopathology slide used Masson’s Trichom and 100x enlargement, so then analyzing the density of collagen by Kruskal-Wallis and Mann-Whitney. Result: There were significant differences in collagen between K1 and K2 (p=0,037), K1 and K3 (p=0,013), K1 and K4 (p=0,002), K1 and K5 (p=0,000). and there were significant differences in collagen between K2 and K5 (p=0,013). But there were no significant differences in collagen between group K2 and K3 (p=1,000), K2 and K4 (p=0,288). Conclusion: The combination of clindamycin with 200mg Nannochloropsis oculata’s extract having an effect on increasing number of the density of collagen significantly on the healing of mandibular osteomyelitis.

Downloads

Download data is not yet available.

References

Adiwenanto AW and Sutejo. 2007. Management of Osteomielitic Chronic Medical Patient at Dr. Kariadi Semarang in 2001-2005 Periods. Tesis, Universitas Diponegoro, Semarang. Available from http://eprints.undip.ac.id/22318/

Bagheri S and Jo C. 2008. Clinical Review of Oral and Maxillofacial Surgery. Georgia: Mosby-Elsevier. P. 92.

Bayu A. 2009. Hutan mangrove sebagai salah satu sumber produk alam laut. Jakarta: Pusat Penelitian Oseanografi-LIPI. Oseana, 34(2): 23-15.

Cawson R and Odell E. 2008. Cawson’s Essentials of Oral Pathology and Oral Medicine. Philadelphia: Churchill Livingstone–Elsevier. P. 102-99.

Collier M. 2003. Understanding Wound Inflamation. Boston, 99: 63. Available from http://www.nursingtimes.net/home/clinicalzones/wound-care/understanding-woundinflammation/205361.article

Damaiyanti. 2012. Aplikasi Ektrak Air Teripang Emas (Stichopus hermani) Sebagai Akselerator Fibroblas dan Kolagen tipe I Ulkus Traumatikus Mukosa Rongga Mulut Tikus Wistar. Tesis, Universitas Airlangga, Surabaya.

Darsana. 2012. Potensi Daun Binahong (Anredera Cordifolia (Tenore) Steenis) dalam Menghambat Pertumbuhan Bakteri Escheria Coli secara In Vitro. Skripsi, Fakultas Kedokteran Hewan, Universitas Udayana, Denpasar. H. 346.

Fadhilah A. 2013. Daya Hambat Ekstrak Nannochloropsis oculata Terhadap Pertumbuhan Bakteri Enterococcus faecalis. Skripsi, Fakultas Kedokteran Gigi, Universitas Hang Tuah, Surabaya. H. 56

Fretes H, Susanto, Prasetyo B, Limantara. 2012. Karotenoid dari Makroalgae dan Mikroalgae: Potensi Kesehatan Aplikasi dan Bioteknologi. J.Teknol dan Industri Pangan, 23(2): 223-222.

Indraswary R. 2011. Efek Konsentrasi Ekstrak Konsentrasi Ekstrak Buah Adas (Foeniculum vulgare Mill) Topikal Pada Epitalisasi Penyembuhan Luka Gingiva Labial Sprague Dawley In Vivo. Majalah Sultan agung, 59(1): 124.

Jewets, M, adelsberg’s. 2005. Mikrobiologi Kedokteran Alih Bahasa bagian Mikrobiologi Fakultas Kedokteran Gigi Universitas Airlangga. H. 225-224.

Kafaie S, Loh SP, Muhtarrudin N. 2012. Acute and Sub-chronic Toxicological Assessment of Nannochloropsis oculata in Rats. African Journal of Agricultural Research, 7 (7): 1220-1225. Available from www.academicjournals.org/ajar/pdf/pdf2012/19Feb/Kafaieetal.pdf. Diakses 4 April

Konjevic et al. 2011. Prevalence of Mandibular Osteomyelitis in Roe Deer (Capreolus Capreolus) in Slovenia. Journal of wildlife disenses, 47(2): 400-393. Available from http://www.torna.do/s/Prevalence-of-mandibular osteomyelitisin-roe-deer-Capreolus-capreolus-inSlovenia/

Peterson LJ, 2004. Principles of Oral and Maxillofacial Surgery. 2nd ed., London: BC Decker Inc. P. 322-313.

Kusumawati D. 2004. Biologi Hewan Coba. Bersahabat Dengan Hewan Coba. Yogyakarta: Gajah Mada University Press. H. 20.

Novriansyah R. 2008. Perbedaan Kepadatan Kolagen di Sekitar Luka Insisi Tikus Wistar yang Dibalut Kasa Konvensional dan Penutup Oklusif Hidrokoloid Selama 2 dan 14 hari. Tesis, Universitas Diponegoro, Semarang. H. 2017.

Pedlar J, Frame JW. 2001. Oral and Maxillofacial Surgery. Churchill Livingstone: Elsevier, p. Topazian RG, 2002. Oral and Maxillofacial Infections. 4th ed., Philadelphia: W.B Saunders. P. 226-214.

Peterson LJ. 2004. Principles of Oral and Maxillofacial Surgery. 2nd ed., London: BC Decker Inc. P. 322-313.

Raras T M, Dewi D S.L.I, Nugraheny. 2008. Efek Pemberian Ekstrak Daun Sirih (Piper betle Linn) Terhadap Optimalisasi Kepadatan Kolagen Luka Bakar Derajat IIA Pada Tikus Putih (Rattus novergicus) Strain Wistar. Fakultas Kedokteran Universitas Brawijaya. Available from http://webcache.googleusercontent.com/search?q=cache:RCi9jKJtYocJ:old.fk.ub.ac.id/artikel/id/filedownload/keperawatan/MAJA

LAH_Ni%2520Wayan%2520Septi%2520asiasaaalahiiani.icalnlmilfDeeral.Nugraheny_0910720008.pdf+&cd=1&hl=id&ct=clnk.

Rinawati ND. 2011. Daya antibakteri tumbuhan majapahit (Crescentia cujete I) terhadap bakteri Vibrio alginolyticus. Tugas akhir, Jurusan Biologi, Fakultas Matematika Ilmu Pengetahuan Alam, Institut Teknologi Sepuluh November, Surabaya. H. 9.

Rizka, Budipramana, Fauziah. 2008. Kepadatan Kolagen Tipe 1 Pada Luka Operasi Tikus Wistar Yang Mengalami Anemia Karena perdarahan Akut. Jurnal. Fakultas Kedokteran Gigi Universitas Airlangga, Surabaya.

Selvendran, 2013. Studies On /Antimicrobial Compounds From SelectedMarine Phytoplanktons. 4 (2):876-888. Available from http://www.ijpbs.net/cms/php/upload/2200_pdf.pdf. Diakses 15 Augustus 2013.

Smeltzer and Gillapsy. 2000. Molecular Pathogenesis of Staphylococcalf,Osteomyelitis. Department of Microbiology and Immunologi, University of Arkansas of Medical Sciences, Little Rock, Arkansas.

Spagnolo, Greco F, Ciolli R L, Teti A, Posteraro P. 1993. Chronic Stapylococcal osteomyelitis: a new experimental rat model, 61(12):5225 available from http://iai.asm.org/. Diakses 4 April 2013.

Sucahyo B. 2005. Peranan Terapi Oksigen Hiperbarik Hewan a..aaniasaif, pada PerkembanganPenanganan Kasus-kasus Kedokteran Gigi.

Majalah kedokteran gigi. Edisi khusus temu ilmiah IV 11-13: 388.

Sudibyo. 2009. Metodologi Penelitian. Aplikasi Penelitian Bidang Kesehatan. Surabaya: Unesa University Press. H. 106105.

Topazian RG. 2002. Oral and Maxillofacial Infections. 4G,. th ed., Philadelphia: W.B Saunders. P. 226-214.-dC

Yanuhar U. 2011. Pengaruh Pemberian Bahan Aktif Ekstrak Nannochloropsis oculata Terhadap Kadar Radikal Bebas Pada Ikan Kerapu Tikus (Cromileptes altivelis) Yang Terinfeksi Bakteri Vibrio alginolyticus. Jurnal Ilmiah Perikanan dan Kelautan, Vol (1): 2. Available from

http://journal.lib.unair.ac.id/index.php/JIPK /article/download/599/599. Diakses 15 Agustus 2013.

Yeoh SC, MacMahon S, Schifter M. 2005. Chronic Supurative Osteomyelitis of the Mandible: Case Report. Australian Dental Journal. Available from http://www.researchgate.net/publication/7528720_Chronic_suppurative_osteomyelitis_of_the_mandible_case_report.

Downloads

Published

2021-12-01

How to Cite

Faidha Azmi N, Dian Mulawarmanti, & Noengki Prameswari. (2021). Efektifitas Perbandingan Kombinasi Clindamycin dan Ekstrak Nannochloropsis Oculata Terhadap Peningkatan Kepadatan Kolagen pada Osteomielitis Mandibula . DENTA JURNAL KEDOKTERAN GIGI, 9(1), 64–73. Retrieved from https://journal-denta.hangtuah.ac.id/index.php/jurnal/article/view/208

Issue

Vol. 9 No. 1 (2015): Februari

Section

Articles

License

Copyright (c) 2015 DENTA

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-ShareAlike 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 – Definitions.

  1. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.
  2. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.
  3. BY-SA Compatible License means a license listed at creativecommons.org/compatiblelicenses, approved by Creative Commons as essentially the equivalent of this Public License.
  4. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.
  5. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.
  6. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.
  7. License Elements means the license attributes listed in the name of a Creative Commons Public License. The License Elements of this Public License are Attribution and ShareAlike.
  8. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.
  9. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.
  10. Licensor means the individual(s) or entity(ies) granting rights under this Public License.
  11. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.
  12. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.
  13. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 – Scope.

  1. License grant.
    1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:
      1. reproduce and Share the Licensed Material, in whole or in part; and
      2. produce, reproduce, and Share Adapted Material.
    2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.
    3. Term. The term of this Public License is specified in Section 6(a).
    4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a)(4) never produces Adapted Material.
    5. Downstream recipients.
      1. Offer from the Licensor – Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.
      2. Additional offer from the Licensor – Adapted Material. Every recipient of Adapted Material from You automatically receives an offer from the Licensor to exercise the Licensed Rights in the Adapted Material under the conditions of the Adapter’s License You apply.
      3. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.
    6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

  2. Other rights.

    1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.
    2. Patent and trademark rights are not licensed under this Public License.
    3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties.

Section 3 – License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

  1. Attribution.

    1. If You Share the Licensed Material (including in modified form), You must:

      1. retain the following if it is supplied by the Licensor with the Licensed Material:
        1. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);
        2. a copyright notice;
        3. a notice that refers to this Public License;
        4. a notice that refers to the disclaimer of warranties;
        5. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;
      2. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and
      3. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.
    2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.
    3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.
  2. ShareAlike.

    In addition to the conditions in Section 3(a), if You Share Adapted Material You produce, the following conditions also apply.

    1. The Adapter’s License You apply must be a Creative Commons license with the same License Elements, this version or later, or a BY-SA Compatible License.
    2. You must include the text of, or the URI or hyperlink to, the Adapter's License You apply. You may satisfy this condition in any reasonable manner based on the medium, means, and context in which You Share Adapted Material.
    3. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, Adapted Material that restrict exercise of the rights granted under the Adapter's License You apply.

Section 4 – Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

  1. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database;
  2. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material, including for purposes of Section 3(b); and
  3. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 – Disclaimer of Warranties and Limitation of Liability.

  1. Unless otherwise separately undertaken by the Licensor, to the extent possible, the Licensor offers the Licensed Material as-is and as-available, and makes no representations or warranties of any kind concerning the Licensed Material, whether express, implied, statutory, or other. This includes, without limitation, warranties of title, merchantability, fitness for a particular purpose, non-infringement, absence of latent or other defects, accuracy, or the presence or absence of errors, whether or not known or discoverable. Where disclaimers of warranties are not allowed in full or in part, this disclaimer may not apply to You.
  2. To the extent possible, in no event will the Licensor be liable to You on any legal theory (including, without limitation, negligence) or otherwise for any direct, special, indirect, incidental, consequential, punitive, exemplary, or other losses, costs, expenses, or damages arising out of this Public License or use of the Licensed Material, even if the Licensor has been advised of the possibility of such losses, costs, expenses, or damages. Where a limitation of liability is not allowed in full or in part, this limitation may not apply to You.
  1. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 – Term and Termination.

  1. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

  2. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

    1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or
    2. upon express reinstatement by the Licensor.
    For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.
  3. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.
  4. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 – Other Terms and Conditions.

  1. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.
  2. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 – Interpretation.

  1. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.
  2. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.
  3. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.
  4. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.

Most read articles by the same author(s)